The role of sulphonylurea in combination therapy assessed in a trial of sulphonylurea withdrawal. Scandinavian Insulin-Sulphonylurea Study Group Research Team. (Q51560081)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The role of sulphonylurea in combination therapy assessed in a trial of sulphonylurea withdrawal. Scandinavian Insulin-Sulphonylurea Study Group Research Team.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

The role of sulphonylurea in combination therapy assessed in a trial of sulphonylurea withdrawal. Scandinavian Insulin-Sulphonylurea Study Group Research Team. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

object named as

Groop L

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

author name string

Landstedt-Hallin L

1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

Arner P

2

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

Lins PE

3

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

Bolinder J

4

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

Olsen H

5

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

publication date

1 October 1999

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

Diabetic Medicine

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

16

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

10

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

827-834

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

Oral hypoglycemic agents

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Insulin-glyburide combination therapy for non-insulin-dependent diabetes mellitus: a long-term double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Bedtime insulin/daytime glipizide. Effective therapy for sulfonylurea failures in NIDDM.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Comparison of Bedtime NPH or Preprandial Regular Insulin Combined With Glibenclamide in Secondary Sulfonylurea Failure

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone. Glimepiride Combination Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Insulin plus a Sulfonylurea Agent for Treating Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Combined insulin-sulfonylurea therapy in treatment of NIDDM.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Effects of combined insulin-sulfonylurea therapy in type II patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

The significance and interpretation of mildly abnormal oral glucose tolerance

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

A Simple Method for the Determination of Serum Free Insulin Levels in Insulin-treated Patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Effect of a sulfonylurea and insulin on energy expenditure in type II diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Different effects of insulin and oral antidiabetic agents on glucose and energy metabolism in type 2 (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Glyburide in non-insulin-dependent diabetes. Its therapeutic effect in patients with disease poorly controlled by insulin alone

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Efficacy of bedtime NPH insulin with daytime sulfonylurea for subpopulation of type II diabetic subjects.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Identifiers

10.1046/J.1464-5491.1999.00171.X

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

release_tywqccaopbd4nok5xoumyklati

1 reference

https://api.fatcat.wiki/v0/release/tywqccaopbd4nok5xoumyklati

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51560081&oldid=1842576851"